US Patent 9089615 Anti-DLL3 antibodies
Patent 9089615 was granted and assigned to Stemcentrx, Inc. on July, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+162 characters)
Article
Patent abstract
Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09089615 Anti-DLL3 antibodies US Patent 9089615 Anti-DLL3 antibodies
Infobox
Patent Number
090896150
Patent Number
90896150
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
090896150
Date of Patent
July 28, 2015
0Patent Application Number
144668420
Date Filed
August 22, 2014
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09089615 Anti-DLL3 antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09089615
Date of patent
July 28, 2015
Patent application number
14466842
Date Filed
August 22, 2014
Patent primary examiner
Find more entities like US Patent 9089615 Anti-DLL3 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.